An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA

DOI Web Site Web Site 1 Citations
  • Anna L. Gray
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Claire O'Leary
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Aiyin Liao
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Leticia Agúndez
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Amir S. Youshani
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Hélène F. Gleitz
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Helen Parker
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Jessica T. Taylor
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Olivier Danos
    Lysogene, Neuilly-sur-Seine, France.
  • Michaël Hocquemiller
    Lysogene, Neuilly-sur-Seine, France.
  • Nuria Palomar
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • R. Michael Linden
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Els Henckaerts
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Rebecca J. Holley
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Brian W. Bigger
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom

Journal

  • Human Gene Therapy

    Human Gene Therapy 30 (9), 1052-1066, 2019-09-01

    Mary Ann Liebert Inc

Citations (1)*help

See more

Report a problem

Back to top